Global Somatostatin for Injection Supply, Demand and Key Producers, 2023-2029

Description

The global Somatostatin for Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Somatostatin for injection is a synthetic cyclic fourteen amino acid, which is exactly the same as natural growth hormone in chemical structure and action. By intravenous injection, somatostatin inhibits the secretion of growth hormone, thyroid-stimulating hormone, insulin, and glucagon, and suppresses the secretion of gastric acid. It also affects absorption, motility, splanchnic blood flow, and nutritional function of the gastrointestinal tract.

This report studies the global Somatostatin for Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Somatostatin for Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Somatostatin for Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Somatostatin for Injection total production and demand, 2018-2029, (K Units)
Global Somatostatin for Injection total production value, 2018-2029, (USD Million)
Global Somatostatin for Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Somatostatin for Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Somatostatin for Injection domestic production, consumption, key domestic manufacturers and share
Global Somatostatin for Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Somatostatin for Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Somatostatin for Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Somatostatin for Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocon, Ferring Pharmaceuticals, Serum Institute of India, UCB India Private Limited, Eumedica, Merck, Sanofi, PolyPeptide Group and Samarth Life Sciences Pvt, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Somatostatin for Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Somatostatin for Injection Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Somatostatin for Injection Market, Segmentation by Type
    1mg/Vial
    3mg/Vial
    Others

Global Somatostatin for Injection Market, Segmentation by Application
    Hospital
    Clinic

Companies Profiled:
    Biocon
    Ferring Pharmaceuticals
    Serum Institute of India
    UCB India Private Limited
    Eumedica
    Merck
    Sanofi
    PolyPeptide Group
    Samarth Life Sciences Pvt
    Hybio Pharmaceutical
    Yangtze River Pharmaceutical
    Hainan Shuangcheng Pharmaceuticals
    Hainan Zhonghe Pharmaceutical
    Wuhan Hualong
    Qingdao Guoda
    Chengdu Shengnuo
    Kumming Longjin Pharmaceutical

Key Questions Answered
1. How big is the global Somatostatin for Injection market?
2. What is the demand of the global Somatostatin for Injection market?
3. What is the year over year growth of the global Somatostatin for Injection market?
4. What is the production and production value of the global Somatostatin for Injection market?
5. Who are the key producers in the global Somatostatin for Injection market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Somatostatin for Injection Introduction
    1.2 World Somatostatin for Injection Supply & Forecast
        1.2.1 World Somatostatin for Injection Production Value (2018 & 2022 & 2029)
        1.2.2 World Somatostatin for Injection Production (2018-2029)
        1.2.3 World Somatostatin for Injection Pricing Trends (2018-2029)
    1.3 World Somatostatin for Injection Production by Region (Based on Production Site)
        1.3.1 World Somatostatin for Injection Production Value by Region (2018-2029)
        1.3.2 World Somatostatin for Injection Production by Region (2018-2029)
        1.3.3 World Somatostatin for Injection Average Price by Region (2018-2029)
        1.3.4 North America Somatostatin for Injection Production (2018-2029)
        1.3.5 Europe Somatostatin for Injection Production (2018-2029)
        1.3.6 China Somatostatin for Injection Production (2018-2029)
        1.3.7 Japan Somatostatin for Injection Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Somatostatin for Injection Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Somatostatin for Injection Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Somatostatin for Injection Demand (2018-2029)
    2.2 World Somatostatin for Injection Consumption by Region
        2.2.1 World Somatostatin for Injection Consumption by Region (2018-2023)
        2.2.2 World Somatostatin for Injection Consumption Forecast by Region (2024-2029)
    2.3 United States Somatostatin for Injection Consumption (2018-2029)
    2.4 China Somatostatin for Injection Consumption (2018-2029)
    2.5 Europe Somatostatin for Injection Consumption (2018-2029)
    2.6 Japan Somatostatin for Injection Consumption (2018-2029)
    2.7 South Korea Somatostatin for Injection Consumption (2018-2029)
    2.8 ASEAN Somatostatin for Injection Consumption (2018-2029)
    2.9 India Somatostatin for Injection Consumption (2018-2029)

3 World Somatostatin for Injection Manufacturers Competitive Analysis
    3.1 World Somatostatin for Injection Production Value by Manufacturer (2018-2023)
    3.2 World Somatostatin for Injection Production by Manufacturer (2018-2023)
    3.3 World Somatostatin for Injection Average Price by Manufacturer (2018-2023)
    3.4 Somatostatin for Injection Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Somatostatin for Injection Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Somatostatin for Injection in 2022
        3.5.3 Global Concentration Ratios (CR8) for Somatostatin for Injection in 2022
    3.6 Somatostatin for Injection Market: Overall Company Footprint Analysis
        3.6.1 Somatostatin for Injection Market: Region Footprint
        3.6.2 Somatostatin for Injection Market: Company Product Type Footprint
        3.6.3 Somatostatin for Injection Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Somatostatin for Injection Production Value Comparison
        4.1.1 United States VS China: Somatostatin for Injection Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Somatostatin for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Somatostatin for Injection Production Comparison
        4.2.1 United States VS China: Somatostatin for Injection Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Somatostatin for Injection Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Somatostatin for Injection Consumption Comparison
        4.3.1 United States VS China: Somatostatin for Injection Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Somatostatin for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Somatostatin for Injection Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Somatostatin for Injection Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Somatostatin for Injection Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Somatostatin for Injection Production (2018-2023)
    4.5 China Based Somatostatin for Injection Manufacturers and Market Share
        4.5.1 China Based Somatostatin for Injection Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Somatostatin for Injection Production Value (2018-2023)
        4.5.3 China Based Manufacturers Somatostatin for Injection Production (2018-2023)
    4.6 Rest of World Based Somatostatin for Injection Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Somatostatin for Injection Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Somatostatin for Injection Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Somatostatin for Injection Production (2018-2023)

5 Market Analysis by Type
    5.1 World Somatostatin for Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 1mg/Vial
        5.2.2 3mg/Vial
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Somatostatin for Injection Production by Type (2018-2029)
        5.3.2 World Somatostatin for Injection Production Value by Type (2018-2029)
        5.3.3 World Somatostatin for Injection Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Somatostatin for Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
    6.3 Market Segment by Application
        6.3.1 World Somatostatin for Injection Production by Application (2018-2029)
        6.3.2 World Somatostatin for Injection Production Value by Application (2018-2029)
        6.3.3 World Somatostatin for Injection Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Biocon
        7.1.1 Biocon Details
        7.1.2 Biocon Major Business
        7.1.3 Biocon Somatostatin for Injection Product and Services
        7.1.4 Biocon Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Biocon Recent Developments/Updates
        7.1.6 Biocon Competitive Strengths & Weaknesses
    7.2 Ferring Pharmaceuticals
        7.2.1 Ferring Pharmaceuticals Details
        7.2.2 Ferring Pharmaceuticals Major Business
        7.2.3 Ferring Pharmaceuticals Somatostatin for Injection Product and Services
        7.2.4 Ferring Pharmaceuticals Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Ferring Pharmaceuticals Recent Developments/Updates
        7.2.6 Ferring Pharmaceuticals Competitive Strengths & Weaknesses
    7.3 Serum Institute of India
        7.3.1 Serum Institute of India Details
        7.3.2 Serum Institute of India Major Business
        7.3.3 Serum Institute of India Somatostatin for Injection Product and Services
        7.3.4 Serum Institute of India Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Serum Institute of India Recent Developments/Updates
        7.3.6 Serum Institute of India Competitive Strengths & Weaknesses
    7.4 UCB India Private Limited
        7.4.1 UCB India Private Limited Details
        7.4.2 UCB India Private Limited Major Business
        7.4.3 UCB India Private Limited Somatostatin for Injection Product and Services
        7.4.4 UCB India Private Limited Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 UCB India Private Limited Recent Developments/Updates
        7.4.6 UCB India Private Limited Competitive Strengths & Weaknesses
    7.5 Eumedica
        7.5.1 Eumedica Details
        7.5.2 Eumedica Major Business
        7.5.3 Eumedica Somatostatin for Injection Product and Services
        7.5.4 Eumedica Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Eumedica Recent Developments/Updates
        7.5.6 Eumedica Competitive Strengths & Weaknesses
    7.6 Merck
        7.6.1 Merck Details
        7.6.2 Merck Major Business
        7.6.3 Merck Somatostatin for Injection Product and Services
        7.6.4 Merck Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Merck Recent Developments/Updates
        7.6.6 Merck Competitive Strengths & Weaknesses
    7.7 Sanofi
        7.7.1 Sanofi Details
        7.7.2 Sanofi Major Business
        7.7.3 Sanofi Somatostatin for Injection Product and Services
        7.7.4 Sanofi Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Sanofi Recent Developments/Updates
        7.7.6 Sanofi Competitive Strengths & Weaknesses
    7.8 PolyPeptide Group
        7.8.1 PolyPeptide Group Details
        7.8.2 PolyPeptide Group Major Business
        7.8.3 PolyPeptide Group Somatostatin for Injection Product and Services
        7.8.4 PolyPeptide Group Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 PolyPeptide Group Recent Developments/Updates
        7.8.6 PolyPeptide Group Competitive Strengths & Weaknesses
    7.9 Samarth Life Sciences Pvt
        7.9.1 Samarth Life Sciences Pvt Details
        7.9.2 Samarth Life Sciences Pvt Major Business
        7.9.3 Samarth Life Sciences Pvt Somatostatin for Injection Product and Services
        7.9.4 Samarth Life Sciences Pvt Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Samarth Life Sciences Pvt Recent Developments/Updates
        7.9.6 Samarth Life Sciences Pvt Competitive Strengths & Weaknesses
    7.10 Hybio Pharmaceutical
        7.10.1 Hybio Pharmaceutical Details
        7.10.2 Hybio Pharmaceutical Major Business
        7.10.3 Hybio Pharmaceutical Somatostatin for Injection Product and Services
        7.10.4 Hybio Pharmaceutical Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Hybio Pharmaceutical Recent Developments/Updates
        7.10.6 Hybio Pharmaceutical Competitive Strengths & Weaknesses
    7.11 Yangtze River Pharmaceutical
        7.11.1 Yangtze River Pharmaceutical Details
        7.11.2 Yangtze River Pharmaceutical Major Business
        7.11.3 Yangtze River Pharmaceutical Somatostatin for Injection Product and Services
        7.11.4 Yangtze River Pharmaceutical Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Yangtze River Pharmaceutical Recent Developments/Updates
        7.11.6 Yangtze River Pharmaceutical Competitive Strengths & Weaknesses
    7.12 Hainan Shuangcheng Pharmaceuticals
        7.12.1 Hainan Shuangcheng Pharmaceuticals Details
        7.12.2 Hainan Shuangcheng Pharmaceuticals Major Business
        7.12.3 Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Product and Services
        7.12.4 Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
        7.12.6 Hainan Shuangcheng Pharmaceuticals Competitive Strengths & Weaknesses
    7.13 Hainan Zhonghe Pharmaceutical
        7.13.1 Hainan Zhonghe Pharmaceutical Details
        7.13.2 Hainan Zhonghe Pharmaceutical Major Business
        7.13.3 Hainan Zhonghe Pharmaceutical Somatostatin for Injection Product and Services
        7.13.4 Hainan Zhonghe Pharmaceutical Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Hainan Zhonghe Pharmaceutical Recent Developments/Updates
        7.13.6 Hainan Zhonghe Pharmaceutical Competitive Strengths & Weaknesses
    7.14 Wuhan Hualong
        7.14.1 Wuhan Hualong Details
        7.14.2 Wuhan Hualong Major Business
        7.14.3 Wuhan Hualong Somatostatin for Injection Product and Services
        7.14.4 Wuhan Hualong Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Wuhan Hualong Recent Developments/Updates
        7.14.6 Wuhan Hualong Competitive Strengths & Weaknesses
    7.15 Qingdao Guoda
        7.15.1 Qingdao Guoda Details
        7.15.2 Qingdao Guoda Major Business
        7.15.3 Qingdao Guoda Somatostatin for Injection Product and Services
        7.15.4 Qingdao Guoda Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Qingdao Guoda Recent Developments/Updates
        7.15.6 Qingdao Guoda Competitive Strengths & Weaknesses
    7.16 Chengdu Shengnuo
        7.16.1 Chengdu Shengnuo Details
        7.16.2 Chengdu Shengnuo Major Business
        7.16.3 Chengdu Shengnuo Somatostatin for Injection Product and Services
        7.16.4 Chengdu Shengnuo Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Chengdu Shengnuo Recent Developments/Updates
        7.16.6 Chengdu Shengnuo Competitive Strengths & Weaknesses
    7.17 Kumming Longjin Pharmaceutical
        7.17.1 Kumming Longjin Pharmaceutical Details
        7.17.2 Kumming Longjin Pharmaceutical Major Business
        7.17.3 Kumming Longjin Pharmaceutical Somatostatin for Injection Product and Services
        7.17.4 Kumming Longjin Pharmaceutical Somatostatin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Kumming Longjin Pharmaceutical Recent Developments/Updates
        7.17.6 Kumming Longjin Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Somatostatin for Injection Industry Chain
    8.2 Somatostatin for Injection Upstream Analysis
        8.2.1 Somatostatin for Injection Core Raw Materials
        8.2.2 Main Manufacturers of Somatostatin for Injection Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Somatostatin for Injection Production Mode
    8.6 Somatostatin for Injection Procurement Model
    8.7 Somatostatin for Injection Industry Sales Model and Sales Channels
        8.7.1 Somatostatin for Injection Sales Model
        8.7.2 Somatostatin for Injection Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Somatostatin for Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Somatostatin for Injection Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Somatostatin for Injection Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Somatostatin for Injection Production Value Market Share by Region (2018-2023)
    Table 5. World Somatostatin for Injection Production Value Market Share by Region (2024-2029)
    Table 6. World Somatostatin for Injection Production by Region (2018-2023) & (K Units)
    Table 7. World Somatostatin for Injection Production by Region (2024-2029) & (K Units)
    Table 8. World Somatostatin for Injection Production Market Share by Region (2018-2023)
    Table 9. World Somatostatin for Injection Production Market Share by Region (2024-2029)
    Table 10. World Somatostatin for Injection Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Somatostatin for Injection Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Somatostatin for Injection Major Market Trends
    Table 13. World Somatostatin for Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Somatostatin for Injection Consumption by Region (2018-2023) & (K Units)
    Table 15. World Somatostatin for Injection Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Somatostatin for Injection Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Somatostatin for Injection Producers in 2022
    Table 18. World Somatostatin for Injection Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Somatostatin for Injection Producers in 2022
    Table 20. World Somatostatin for Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Somatostatin for Injection Company Evaluation Quadrant
    Table 22. World Somatostatin for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Somatostatin for Injection Production Site of Key Manufacturer
    Table 24. Somatostatin for Injection Market: Company Product Type Footprint
    Table 25. Somatostatin for Injection Market: Company Product Application Footprint
    Table 26. Somatostatin for Injection Competitive Factors
    Table 27. Somatostatin for Injection New Entrant and Capacity Expansion Plans
    Table 28. Somatostatin for Injection Mergers & Acquisitions Activity
    Table 29. United States VS China Somatostatin for Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Somatostatin for Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Somatostatin for Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Somatostatin for Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Somatostatin for Injection Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Somatostatin for Injection Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Somatostatin for Injection Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Somatostatin for Injection Production Market Share (2018-2023)
    Table 37. China Based Somatostatin for Injection Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Somatostatin for Injection Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Somatostatin for Injection Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Somatostatin for Injection Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Somatostatin for Injection Production Market Share (2018-2023)
    Table 42. Rest of World Based Somatostatin for Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Somatostatin for Injection Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Somatostatin for Injection Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Somatostatin for Injection Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Somatostatin for Injection Production Market Share (2018-2023)
    Table 47. World Somatostatin for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Somatostatin for Injection Production by Type (2018-2023) & (K Units)
    Table 49. World Somatostatin for Injection Production by Type (2024-2029) & (K Units)
    Table 50. World Somatostatin for Injection Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Somatostatin for Injection Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Somatostatin for Injection Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Somatostatin for Injection Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Somatostatin for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Somatostatin for Injection Production by Application (2018-2023) & (K Units)
    Table 56. World Somatostatin for Injection Production by Application (2024-2029) & (K Units)
    Table 57. World Somatostatin for Injection Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Somatostatin for Injection Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Somatostatin for Injection Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Somatostatin for Injection Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Biocon Basic Information, Manufacturing Base and Competitors
    Table 62. Biocon Major Business
    Table 63. Biocon Somatostatin for Injection Product and Services
    Table 64. Biocon Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Biocon Recent Developments/Updates
    Table 66. Biocon Competitive Strengths & Weaknesses
    Table 67. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 68. Ferring Pharmaceuticals Major Business
    Table 69. Ferring Pharmaceuticals Somatostatin for Injection Product and Services
    Table 70. Ferring Pharmaceuticals Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Ferring Pharmaceuticals Recent Developments/Updates
    Table 72. Ferring Pharmaceuticals Competitive Strengths & Weaknesses
    Table 73. Serum Institute of India Basic Information, Manufacturing Base and Competitors
    Table 74. Serum Institute of India Major Business
    Table 75. Serum Institute of India Somatostatin for Injection Product and Services
    Table 76. Serum Institute of India Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Serum Institute of India Recent Developments/Updates
    Table 78. Serum Institute of India Competitive Strengths & Weaknesses
    Table 79. UCB India Private Limited Basic Information, Manufacturing Base and Competitors
    Table 80. UCB India Private Limited Major Business
    Table 81. UCB India Private Limited Somatostatin for Injection Product and Services
    Table 82. UCB India Private Limited Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. UCB India Private Limited Recent Developments/Updates
    Table 84. UCB India Private Limited Competitive Strengths & Weaknesses
    Table 85. Eumedica Basic Information, Manufacturing Base and Competitors
    Table 86. Eumedica Major Business
    Table 87. Eumedica Somatostatin for Injection Product and Services
    Table 88. Eumedica Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Eumedica Recent Developments/Updates
    Table 90. Eumedica Competitive Strengths & Weaknesses
    Table 91. Merck Basic Information, Manufacturing Base and Competitors
    Table 92. Merck Major Business
    Table 93. Merck Somatostatin for Injection Product and Services
    Table 94. Merck Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Merck Recent Developments/Updates
    Table 96. Merck Competitive Strengths & Weaknesses
    Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 98. Sanofi Major Business
    Table 99. Sanofi Somatostatin for Injection Product and Services
    Table 100. Sanofi Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Sanofi Recent Developments/Updates
    Table 102. Sanofi Competitive Strengths & Weaknesses
    Table 103. PolyPeptide Group Basic Information, Manufacturing Base and Competitors
    Table 104. PolyPeptide Group Major Business
    Table 105. PolyPeptide Group Somatostatin for Injection Product and Services
    Table 106. PolyPeptide Group Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. PolyPeptide Group Recent Developments/Updates
    Table 108. PolyPeptide Group Competitive Strengths & Weaknesses
    Table 109. Samarth Life Sciences Pvt Basic Information, Manufacturing Base and Competitors
    Table 110. Samarth Life Sciences Pvt Major Business
    Table 111. Samarth Life Sciences Pvt Somatostatin for Injection Product and Services
    Table 112. Samarth Life Sciences Pvt Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Samarth Life Sciences Pvt Recent Developments/Updates
    Table 114. Samarth Life Sciences Pvt Competitive Strengths & Weaknesses
    Table 115. Hybio Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 116. Hybio Pharmaceutical Major Business
    Table 117. Hybio Pharmaceutical Somatostatin for Injection Product and Services
    Table 118. Hybio Pharmaceutical Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Hybio Pharmaceutical Recent Developments/Updates
    Table 120. Hybio Pharmaceutical Competitive Strengths & Weaknesses
    Table 121. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 122. Yangtze River Pharmaceutical Major Business
    Table 123. Yangtze River Pharmaceutical Somatostatin for Injection Product and Services
    Table 124. Yangtze River Pharmaceutical Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Yangtze River Pharmaceutical Recent Developments/Updates
    Table 126. Yangtze River Pharmaceutical Competitive Strengths & Weaknesses
    Table 127. Hainan Shuangcheng Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 128. Hainan Shuangcheng Pharmaceuticals Major Business
    Table 129. Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Product and Services
    Table 130. Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
    Table 132. Hainan Shuangcheng Pharmaceuticals Competitive Strengths & Weaknesses
    Table 133. Hainan Zhonghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 134. Hainan Zhonghe Pharmaceutical Major Business
    Table 135. Hainan Zhonghe Pharmaceutical Somatostatin for Injection Product and Services
    Table 136. Hainan Zhonghe Pharmaceutical Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Hainan Zhonghe Pharmaceutical Recent Developments/Updates
    Table 138. Hainan Zhonghe Pharmaceutical Competitive Strengths & Weaknesses
    Table 139. Wuhan Hualong Basic Information, Manufacturing Base and Competitors
    Table 140. Wuhan Hualong Major Business
    Table 141. Wuhan Hualong Somatostatin for Injection Product and Services
    Table 142. Wuhan Hualong Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Wuhan Hualong Recent Developments/Updates
    Table 144. Wuhan Hualong Competitive Strengths & Weaknesses
    Table 145. Qingdao Guoda Basic Information, Manufacturing Base and Competitors
    Table 146. Qingdao Guoda Major Business
    Table 147. Qingdao Guoda Somatostatin for Injection Product and Services
    Table 148. Qingdao Guoda Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Qingdao Guoda Recent Developments/Updates
    Table 150. Qingdao Guoda Competitive Strengths & Weaknesses
    Table 151. Chengdu Shengnuo Basic Information, Manufacturing Base and Competitors
    Table 152. Chengdu Shengnuo Major Business
    Table 153. Chengdu Shengnuo Somatostatin for Injection Product and Services
    Table 154. Chengdu Shengnuo Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Chengdu Shengnuo Recent Developments/Updates
    Table 156. Kumming Longjin Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 157. Kumming Longjin Pharmaceutical Major Business
    Table 158. Kumming Longjin Pharmaceutical Somatostatin for Injection Product and Services
    Table 159. Kumming Longjin Pharmaceutical Somatostatin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 160. Global Key Players of Somatostatin for Injection Upstream (Raw Materials)
    Table 161. Somatostatin for Injection Typical Customers
    Table 162. Somatostatin for Injection Typical Distributors
List of Figure
    Figure 1. Somatostatin for Injection Picture
    Figure 2. World Somatostatin for Injection Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Somatostatin for Injection Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Somatostatin for Injection Production (2018-2029) & (K Units)
    Figure 5. World Somatostatin for Injection Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Somatostatin for Injection Production Value Market Share by Region (2018-2029)
    Figure 7. World Somatostatin for Injection Production Market Share by Region (2018-2029)
    Figure 8. North America Somatostatin for Injection Production (2018-2029) & (K Units)
    Figure 9. Europe Somatostatin for Injection Production (2018-2029) & (K Units)
    Figure 10. China Somatostatin for Injection Production (2018-2029) & (K Units)
    Figure 11. Japan Somatostatin for Injection Production (2018-2029) & (K Units)
    Figure 12. Somatostatin for Injection Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Somatostatin for Injection Consumption (2018-2029) & (K Units)
    Figure 15. World Somatostatin for Injection Consumption Market Share by Region (2018-2029)
    Figure 16. United States Somatostatin for Injection Consumption (2018-2029) & (K Units)
    Figure 17. China Somatostatin for Injection Consumption (2018-2029) & (K Units)
    Figure 18. Europe Somatostatin for Injection Consumption (2018-2029) & (K Units)
    Figure 19. Japan Somatostatin for Injection Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Somatostatin for Injection Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Somatostatin for Injection Consumption (2018-2029) & (K Units)
    Figure 22. India Somatostatin for Injection Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Somatostatin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Somatostatin for Injection Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Somatostatin for Injection Markets in 2022
    Figure 26. United States VS China: Somatostatin for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Somatostatin for Injection Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Somatostatin for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Somatostatin for Injection Production Market Share 2022
    Figure 30. China Based Manufacturers Somatostatin for Injection Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Somatostatin for Injection Production Market Share 2022
    Figure 32. World Somatostatin for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Somatostatin for Injection Production Value Market Share by Type in 2022
    Figure 34. 1mg/Vial
    Figure 35. 3mg/Vial
    Figure 36. Others
    Figure 37. World Somatostatin for Injection Production Market Share by Type (2018-2029)
    Figure 38. World Somatostatin for Injection Production Value Market Share by Type (2018-2029)
    Figure 39. World Somatostatin for Injection Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Somatostatin for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Somatostatin for Injection Production Value Market Share by Application in 2022
    Figure 42. Hospital
    Figure 43. Clinic
    Figure 44. World Somatostatin for Injection Production Market Share by Application (2018-2029)
    Figure 45. World Somatostatin for Injection Production Value Market Share by Application (2018-2029)
    Figure 46. World Somatostatin for Injection Average Price by Application (2018-2029) & (US$/Unit)
    Figure 47. Somatostatin for Injection Industry Chain
    Figure 48. Somatostatin for Injection Procurement Model
    Figure 49. Somatostatin for Injection Sales Model
    Figure 50. Somatostatin for Injection Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source